Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-24 @ 9:34 PM
NCT ID:
NCT02612532
Eligibility Criteria:
Recruitment for these patients will be done from NHS hospitals whom identify or follow-up on patients suspected of having lung cancer.
* Inclusion criteria:
* Older than 18 years at time of consent
* Referred for investigation due to suspicion of lung cancer
* Referral based on suspicious symptoms
* Referral based on suspicious finding on imaging, including CTscan with indeterminate nodule requiring follow-up evaluation.
* Capable of understanding written and/or spoken language
* Able to provide informed consent
* Exclusion criteria:
* (Anticipated) inability to complete breath sampling procedure due to e.g. hyper- or hypo-ventilation, respiratory failure or claustrophobia when wearing the sampling mask
* Participating in a Clinical Trial Investigational Medicinal Product (CTIMP)
* Pulmonary function test with metacholine or beta-2-sympatico mimetic in last 2 hours.
* Any lung biopsy in the past 48 hours
* Currently undergoing anti-cancer treatment for lung cancer
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02612532
Study Brief:
Protocol Section:
NCT02612532